| abstract |
Generally, and in one form, the present invention is a method of treating one or more cancerous growing cells comprising the step of contacting one or more cancerous growing cells with an antibody to RLIP76, or a fragment of RLIP76. In yet another form, the present invention is a method of treating one or more cancerous growing cells comprising the step of contacting one or more cancerous growing cells with RLIP76 IgG. In still another form, the present invention is a pharmaceutical composition used to increases the accumulation of one or more chemotherapeutic agents inside a cancerous growing cell comprising one or more chemotherapeutic agents used in combination with an antibody to RLIP76, wherein the antibody comprises all or an effective portion thereof and when to bound a cancerous growing cell will promote the accumulation of one or more chemotherapeutic agents within the cell. |